| 000 | 01452 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513034759.0 | ||
| 264 | 0 | _c19950908 | |
| 008 | 199509s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeltzer, L T | |
| 245 | 0 | 0 |
_aCI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cAug 1995 |
||
| 300 |
_a912-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApomorphine _xpharmacology |
| 650 | 0 | 4 |
_aAutoreceptors _xdrug effects |
| 650 | 0 | 4 |
_aAvoidance Learning _xdrug effects |
| 650 | 0 | 4 |
_aBasal Ganglia Diseases _xchemically induced |
| 650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSaimiri |
| 700 | 1 | _aChristoffersen, C L | |
| 700 | 1 | _aCorbin, A E | |
| 700 | 1 | _aNinteman, F W | |
| 700 | 1 | _aSerpa, K A | |
| 700 | 1 | _aWiley, J N | |
| 700 | 1 | _aWise, L D | |
| 700 | 1 | _aHeffner, T G | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 274 _gno. 2 _gp. 912-20 |
|
| 999 |
_c7636190 _d7636190 |
||